Evotec Lands $2.9M Gates Foundation Grant Giving Global Health Researchers Continued Access To Stem Cell Platform For Early Drug Safety Assessment

Benzinga · 2d ago
  • New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidates
  • Evotec's human stem cell-based platform enables better-informed decisions regarding which drug candidates to advance into clinical testing
  • Continued collaboration underscores Evotec's capabilities in advanced human cell-based drug discovery technologies